Vaccine Development Related News
Covid vaccines prevented 19.8 million deaths in the first year
A modelling study has quantified that Covid vaccines have prevented 19.8 million out of a potential 31.4 million deaths in the first year.
In the...
Versatile Accum technology for various immune-oncology needs
Defence Therapeutics explains how its Accum™ technology can enhance the delivery of tumour and infectious disease-specific therapeutics.
The principal technology developed by Defence Therapeutics (DT)...
Cancer vaccine developed using Oxford-AstraZeneca vaccine technology
Scientists are utilising the same technology used in the creation of the Oxford-AstraZeneca COVID-19 jab to develop a vaccine to treat cancer.
Researchers at the...
$1.5m funding will further research towards TB vaccine
The VALIDATE Network has received a $1.5m funding boost to support its development of a tuberculosis (TB) vaccine.
The Bill & Melinda Gates Foundation have...
Research shows CoronaVac COVID-19 vaccine is safe and effective
An interim analysis of the phase 3 control trial has proven the CoronaVac COVID-19 vaccine to be safe and effective at preventing infection.
The findings,...
Cancer vaccine shows long-lasting anti-tumoural response
A pre-clinical study has demonstrated the anti-tumoural efficacy of the AccuVAC-D001 cancer vaccine.
Developed by biotechnology company Defence Therapeutics Inc., the AccuVAC-D001 cancer vaccine demonstrated...
EU Vaccine Strategy: supporting COVID-19 therapeutics development
The European Commission will be complementing the EU Vaccines Strategy by supporting the development of COVID-19 therapeutics, including the treatment of long-COVID.
As part of...
Cutting-edge UK lab to fast-track COVID-19 variant vaccines
A new state-of-the-art lab in the UK will test the effectiveness of vaccines against new variants of COVID-19.
The new testing lab based at Porton...
COVID-19 vaccines and the route out of the pandemic
The development and rollout of vaccines against COVID-19 form a key step in the journey towards a post-pandemic world.
For the past year, the coronavirus...
COVID-19 vaccine modifications to be fast-tracked to tackle variants
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed that modifications to the COVID-19 vaccines will be fast-tracked to help tackle new variants.
COVID-19...
Nanoparticle-delivered COVID-19 vaccine shows strong efficacy
A new nanoparticle-delivered COVID-19 vaccine candidate has shown promising results in preclinical studies.
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health...
Single-dose Janssen COVID-19 vaccine shows 66% effectiveness
New data from the Phase III studies of Janssen’s single-dose COVID-19 vaccine candidate has shown 66% effectiveness in preventing coronavirus in participants.
The UK has...
World first COVID-19 smart vaccine patch
In a world first development, researchers are creating a COVID-19 smart vaccine patch that will deliver the vaccine as well as measure its efficacy.
The...
Oxford University COVID-19 vaccine roll out begins
The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today.
The...
European Commission concludes Novavax talks for COVID-19 vaccine
The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine.
The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK
Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
AstraZeneca to test component of Russia’s Sputnik V vaccine
AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus.
Following the preliminary...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
One step closer to a COVID-19 vaccine for the UK
Pfizer and BioNTech SE have announced their mRNA-based COVID-19 vaccine candidate has demonstrated evidence of efficacy against COVID-19 in participants without prior evidence of infection.
The...
New UK laws allow healthcare workers to administer vaccines
Changes to the Human Medicine Regulations 2012 have now come into force in the UK, with new laws which will allow healthcare workers to...
